Doc, we all want unilife to succeed, but to amgen, with a revenue of 21.6 billion, and net profit of $6.9 billion, our contract is but a smidgen on their underlying profit.
We are ONE contract away from lift off, but the million dollar question is, are we getting that contract. Hikma agreement was 3 years ago, Sanofi 2014, and yet we are getting zilch atm, we don't even know where we stand in their regard, THREE years after the agreement signing.
Anyway, I did put quite a bit in unilife myself, and it's pretty red at the moment, I hope to see the day we sky-rocket to a bona fide company running on full cylinders, but at this stage, I wouldn't recommend anyone to invest in the company until we hear some concrete news regarding our future.
UNS Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
